Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Alliance Global Partners analyst Ben Haynor maintains Profound Medical (NASDAQ:PROF) with a Buy and lowers the price target ...
Stifel analyst Rick Wise maintains Profound Medical (NASDAQ:PROF) with a Hold and lowers the price target from $11 to $9.
Profound Medical (NASDAQ:PROF) reported quarterly losses of $(0.420) per share which missed the analyst consensus estimate of $...
Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on rev...
The closing of the Private Placement is expected to occur on or about January 17, 2024, subject to customary closing conditions.
Alliance Global Partners analyst Ben Haynor maintains Profound Medical (NASDAQ:PROF) with a Buy and lowers the price target ...
Profound Medical Corp. (NASDAQ:PROF, TSX:PRN) ("Profound" or the "Company"), a commercial-stage medical device ...
With U.S. stock futures trading slightly higher this morning on Thursday, some of the stocks that may grab investor focus today...
